Evaluating the efficacy of sequential biologic therapies for rheumatoid arthritis patients with an inadequate response to tumor necrosis factor-α inhibitors

American college of rheumatology preliminary definition of improvement in rheumatoid arthritis

David T. Felson, Jennifer J. Anderson, Maarten Boers et al. · Arthritis & Rheumatism · 1995 · 2.8K citations

Rituximab for rheumatoid arthritis refractory to anti–tumor necrosis factor therapy: Results of a multicenter, randomized, double‐blind, placebo‐controlled, phase III trial evaluating primary efficacy and safety at twenty‐four weeks

Stanley Cohen, Paul Emery, Maria Greenwald et al. · Arthritis & Rheumatism · 2006 · 1.6K citations

American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease‐modifying antirheumatic drugs in rheumatoid arthritis

Kenneth G. Saag, Gim Gee Teng, Nivedita M. Patkar et al. · Arthritis Care & Research · 2008 · 1.5K citations

Orthopedic Physical Therapy, Pharmacotherapy, Inflammatory Arthritis +20

Abatacept for Rheumatoid Arthritis Refractory to Tumor Necrosis Factor α Inhibition

Mark C. Genovese, Jean‐Claude Becker, Michael Schiff et al. · New England Journal of Medicine · 2005 · 1.2K citations · Full text

IL-6 receptor inhibition with tocilizumab improves treatment outcomes in patients with rheumatoid arthritis refractory to anti-tumour necrosis factor biologicals: results from a 24-week multicentre randomised placebo-controlled trial

Paul Emery, Edward Keystone, Hans‐Peter Tony et al. · Annals of the Rheumatic Diseases · 2008 · 1.1K citations · Full text